Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3019990820;90821;90822 chr2:178552305;178552304;178552303chr2:179417032;179417031;179417030
N2AB2855885897;85898;85899 chr2:178552305;178552304;178552303chr2:179417032;179417031;179417030
N2A2763183116;83117;83118 chr2:178552305;178552304;178552303chr2:179417032;179417031;179417030
N2B2113463625;63626;63627 chr2:178552305;178552304;178552303chr2:179417032;179417031;179417030
Novex-12125964000;64001;64002 chr2:178552305;178552304;178552303chr2:179417032;179417031;179417030
Novex-22132664201;64202;64203 chr2:178552305;178552304;178552303chr2:179417032;179417031;179417030
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Ig-148
  • Domain position: 68
  • Structural Position: 151
  • Q(SASA): 0.329
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/E rs757271306 -0.127 0.994 N 0.668 0.358 0.39798585902 gnomAD-2.1.1 4.05E-06 None None None None I None 0 0 None 0 5.58E-05 None 0 None 0 0 0
G/E rs757271306 -0.127 0.994 N 0.668 0.358 0.39798585902 gnomAD-3.1.2 6.57E-06 None None None None I None 0 0 0 0 1.92901E-04 None 0 0 0 0 0
G/E rs757271306 -0.127 0.994 N 0.668 0.358 0.39798585902 gnomAD-4.0.0 2.02988E-06 None None None None I None 0 0 None 0 2.26912E-04 None 0 0 0 0 0
G/R None None 0.997 N 0.75 0.338 0.404034981753 gnomAD-4.0.0 3.18963E-06 None None None None I None 0 0 None 0 0 None 0 0 0 2.88342E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.108 likely_benign 0.1022 benign -0.425 Destabilizing 0.198 N 0.225 neutral N 0.356221278 None None I
G/C 0.2622 likely_benign 0.2631 benign -0.813 Destabilizing 1.0 D 0.749 deleterious None None None None I
G/D 0.5937 likely_pathogenic 0.6036 pathogenic -0.439 Destabilizing 0.99 D 0.625 neutral None None None None I
G/E 0.4209 ambiguous 0.4001 ambiguous -0.528 Destabilizing 0.994 D 0.668 neutral N 0.428350735 None None I
G/F 0.8012 likely_pathogenic 0.7743 pathogenic -0.857 Destabilizing 0.999 D 0.774 deleterious None None None None I
G/H 0.6439 likely_pathogenic 0.6242 pathogenic -0.906 Destabilizing 0.999 D 0.734 prob.delet. None None None None I
G/I 0.4939 ambiguous 0.493 ambiguous -0.197 Destabilizing 0.998 D 0.79 deleterious None None None None I
G/K 0.6412 likely_pathogenic 0.6124 pathogenic -0.958 Destabilizing 0.995 D 0.665 neutral None None None None I
G/L 0.6279 likely_pathogenic 0.6105 pathogenic -0.197 Destabilizing 0.995 D 0.713 prob.delet. None None None None I
G/M 0.6308 likely_pathogenic 0.6247 pathogenic -0.29 Destabilizing 1.0 D 0.747 deleterious None None None None I
G/N 0.5287 ambiguous 0.5422 ambiguous -0.612 Destabilizing 0.643 D 0.271 neutral None None None None I
G/P 0.9771 likely_pathogenic 0.9726 pathogenic -0.232 Destabilizing 0.998 D 0.749 deleterious None None None None I
G/Q 0.4587 ambiguous 0.4283 ambiguous -0.776 Destabilizing 0.998 D 0.765 deleterious None None None None I
G/R 0.4634 ambiguous 0.4392 ambiguous -0.658 Destabilizing 0.997 D 0.75 deleterious N 0.488055186 None None I
G/S 0.1092 likely_benign 0.108 benign -0.887 Destabilizing 0.967 D 0.433 neutral None None None None I
G/T 0.2134 likely_benign 0.2167 benign -0.881 Destabilizing 0.995 D 0.659 neutral None None None None I
G/V 0.3829 ambiguous 0.3747 ambiguous -0.232 Destabilizing 0.994 D 0.716 prob.delet. N 0.492095569 None None I
G/W 0.7146 likely_pathogenic 0.7035 pathogenic -1.16 Destabilizing 1.0 D 0.686 prob.neutral None None None None I
G/Y 0.6802 likely_pathogenic 0.6725 pathogenic -0.739 Destabilizing 1.0 D 0.772 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.